11-77202351-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000260.4(MYO7A):c.5095C>G(p.Gln1699Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00000762 in 1,574,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.5095C>G | p.Gln1699Glu | missense_variant | Exon 37 of 49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.4981C>G | p.Gln1661Glu | missense_variant | Exon 37 of 49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.4948C>G | p.Gln1650Glu | missense_variant | Exon 38 of 50 | 1 | ENSP00000386635.2 | |||
MYO7A | ENST00000458169.2 | c.2521C>G | p.Gln841Glu | missense_variant | Exon 17 of 29 | 1 | ENSP00000417017.2 | |||
MYO7A | ENST00000670577.1 | n.2935C>G | non_coding_transcript_exon_variant | Exon 20 of 32 | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000534 AC: 1AN: 187094Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 100140
GnomAD4 exome AF: 0.00000352 AC: 5AN: 1422400Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 703808
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The Gln1699Glu vari ant in MYO7A has not been reported in individuals with hearing loss. Computation al analyses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhe n2, and SIFT) suggest that the Gln1699Glu variant may not impact the protein, th ough this information is not predictive enough to rule out pathogenicity. In sum mary, the clinical significance of this variant cannot be determined with certai nty; however, based upon the computational data, we lean towards a more likely b enign role. -
Usher syndrome type 1;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Uncertain:1
- -
Usher syndrome type 1B Uncertain:1
- -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYO7A protein function. ClinVar contains an entry for this variant (Variation ID: 178932). This variant has not been reported in the literature in individuals affected with MYO7A-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 1699 of the MYO7A protein (p.Gln1699Glu). -
Usher syndrome type 1;C1832475:Autosomal dominant nonsyndromic hearing loss 11;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at